✦ LIBER ✦

Clinical efficacy of capecitabine as first-line chemotherapy in metastatic breast cancer—How low can you go?

✍ Scribed by Y.S. Yap; A. Kendall; G. Walsh; U. Banerji; S.R.D. Johnston; I.E. Smith; M. O’Brien

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of Capecitabine as First-Line Therap

✍ A. Bashey; S. Sundaram; S. Corringham; V. Jones; D. Lancaster; J. Silva-Gietzen; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 84 KB

6576 Irinotecan and low-dose capecitabin

✍ Farhat, F.; Kattan, J.; Chahine, G.; Naser, F.; Youness, F.; Ghosn, M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

All-oral combination of oral vinorelbine

✍ Tubiana-Mathieu, N; Bougnoux, P; Becquart, D; Chan, A; Conte, P-F; Majois, F; Es 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 203 KB

Efficacy and Safety of Trastuzumab as a

✍ Vogel, C. L. 📂 Article 📅 2002 🏛 American Society of Clinical Oncology 🌐 English ⚖ 88 KB

A randomized phase III study comparing p

✍ Smorenburg, C. H.; de Groot, S. M.; van Leeuwen-Stok, A. E.; Hamaker, M. E.; Wym 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 218 KB

249 Feasibility and Toxicities Associate

✍ C. Seynaeve; H. van Tinteren; A.N.M. Wymenga; J.W.R. Nortier; E. Maartense; F.E. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB